KELSEY CRAWFORD: Open Payments
NPI 1487211819 · GREAT FALLS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 10 payments from 7 companies in 2025. Trend: 2023 $17 · 2024 $190 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $82 |
| Verona Pharma, Inc. | 1 | $32 |
| Lilly USA, LLC | 2 | $30 |
| Organon LLC | 1 | $27 |
| Amgen Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $18 |
Products named: AIRSUPRA, CAPLYTA, Ohtuvayre, MOUNJARO, NEXPLANON, EVENITY, INJECTAFER.
Industry payments across MT — which companies pay providers there.
